Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.
Google Scholar
Fryback, D. G., Dunham, N. C., Palta, M., Hanmer, J., Buechner, J., Cherepanov, D., et al. (2007). US norms for six generic health-related quality-of-life indexes from the national health measurement study. Medical Care,
45(12), 1162–1170.
PubMed
Article
Google Scholar
Gold, M. R., Stevenson, D., & Fryback, D. G. (2002). HALYS and QALYS and DALYS, Oh My: Similarities and differences in summary measures of population health. Annual Review of Public Health,
23, 115–134.
PubMed
Article
Google Scholar
Kaplan, R. M. (2005). Measuring quality of life for policy analysis: Past, present and the future. In W. R. Lenderking & D. A. Revicki (Eds.), Advancing health outcomes research methods and clinical applications. McClean, VA: International Society for Quality of Life Research.
Google Scholar
Lipscomb, J., Drummond, M., Fryback, D., Gold, M., & Revicki, D. (2009). Retaining, and enhancing, the QALY. Value Health,
12(Suppl 1), S18–S26.
PubMed
Article
Google Scholar
Weinstein, M. C., Torrance, G., & McGuire, A. (2009). QALYs: The basics. Value Health,
12(Suppl 1), S5–S9.
PubMed
Article
Google Scholar
Brazier, J., Czoski-Murray, C., Roberts, J., Brown, M., Symonds, T., & Kelleher, C. (2008). Estimation of a preference-based index from a condition-specific measure: The King’s health questionnaire. Medical Decision Making,
28(1), 113–126.
PubMed
Article
Google Scholar
Torrance, G. W. (1986). Measurement of health state utilities for economic appraisal. Journal of Health Economics,
5(1), 1–30.
PubMed
Article
CAS
Google Scholar
Feeny, D., Furlong, W., Torrance, G. W., Goldsmith, C. H., Zhu, Z., DePauw, S., et al. (2002). Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Medical Care,
40(2), 113–128.
PubMed
Article
Google Scholar
Feeny, D., Torrance, G. W., & Furlong, W. (1996). Health utilities index. In B. Spilker (Ed.), Quality of life and pharmacoeconomics in clinical trials. Philadelphia, PA: Lippincott-Raven Press.
Google Scholar
The EuroQol Group. (1990). EuroQol–a new facility for the measurement of health-related quality of life. Health Policy,
16(3), 199–208.
Article
Google Scholar
Brooks, R., Rabin, R., & de Charro, F. (2003). The measurement and valuation of health status using EQ-5D: A European perspective. Dordrecht, Netherlands: Kluwer Academic Publishers.
Google Scholar
Andresen, E. M., Rothenberg, B. M., & Kaplan, R. M. (1998). Performance of a self-administered mailed version of the quality of well-being (QWB-SA) questionnaire among older adults. Medical Care,
36(9), 1349–1360.
PubMed
Article
CAS
Google Scholar
Brown, G. C., Brown, M. M., Sharma, S., Stein, J. D., Roth, Z., Campanella, J. & Beauchamp, G. R. (2005). The burden of age-related macular degeneration: A value-based medicine analysis. Transactions of the American Ophthalmological Society, 103, 173–184; discussion 184–176.
Google Scholar
Brown, M. M., Brown, G. C., Stein, J. D., Roth, Z., Campanella, J., & Beauchamp, G. R. (2005). Age-related macular degeneration: Economic burden and value-based medicine analysis. Canadian Journal of Ophthalmology,
40(3), 277–287.
PubMed
Google Scholar
Espallargues, M., Czoski-Murray, C. J., Bansback, N. J., Carlton, J., Lewis, G. M., Hughes, L. A., et al. (2005). The impact of age-related macular degeneration on health status utility values. Investigative Ophthalmology and Visual Science,
46(11), 4016–4023.
PubMed
Article
Google Scholar
National Institute for Health and Clinical Excellence. (2008). Guide to the methods of technology appraisal.
Kaplan, R. M., Tally, S., Hays, R. D., Feeny, D., Ganiats, T. G., Palta, M. & Fryback, D. (2011). Responsiveness of five preference-based indexes in cataract and heart failure patients. Journal of Clinical Epidemiology, 64, 497–506.
Google Scholar
Clarke, P., Gray, A., Legood, R., Briggs, A., & Holman, R. (2003). The impact of diabetes-related complications on healthcare costs: results from the United Kingdom prospective diabetes study (UKPDS study no. 65). Diabetic Medicine,
20(6), 442–450.
PubMed
Article
CAS
Google Scholar
Brown, M. M., Brown, G. C., Sharma, S., & Shah, G. (1999). Utility values and diabetic retinopathy. American Journal of Ophthalmology,
128(3), 324–330.
PubMed
Article
CAS
Google Scholar
Brown, G. C., Sharma, S., Brown, M. M., & Kistler, J. (2000). Utility values and age-related macular degeneration. Archives of Ophthalmology,
118(1), 47–51.
PubMed
CAS
Google Scholar
Brown, M. M., Brown, G. C., Sharma, S., Landy, J., & Bakal, J. (2002). Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration. Archives of Ophthalmology,
120(4), 481–484.
PubMed
Google Scholar
Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics,
21(2), 271–292.
PubMed
Article
Google Scholar
Revicki, D. A., Leidy, N. K., Brennan-Diemer, F., Sorensen, S., & Togias, A. (1998). Integrating patient preferences into health outcomes assessment: The multiattribute Asthma symptom utility index. Chest,
114(4), 998–1007.
PubMed
Article
CAS
Google Scholar
Revicki, D. A., Leidy, N. K., Brennan-Diemer, F., Thompson, C., & Togias, A. (1998). Development and preliminary validation of the multiattribute Rhinitis symptom utility index. Quality of Life Research,
7(8), 693–702.
PubMed
Article
CAS
Google Scholar
Young, T., Yang, Y., Brazier, J. E., Tsuchiya, A., & Coyne, K. (2009). The first stage of developing preference-based measures: constructing a health-state classification using Rasch analysis. Quality of Life Research,
18(2), 253–265.
PubMed
Article
Google Scholar
Lenert, L. A., Sherbourne, C. D., Sugar, C., & Wells, K. B. (2000). Estimation of utilities for the effects of depression from the SF-12. Medical Care,
38(7), 763–770.
PubMed
Article
CAS
Google Scholar
Lo, P. S., Tong, M. C., Revicki, D. A., Lee, C. C., Woo, J. K., Lam, H. C., et al. (2006). Rhinitis symptom utility index (RSUI) in Chinese subjects: a multiattribute patient-preference approach. Quality of Life Research,
15(5), 877–887.
PubMed
Article
Google Scholar
Mangione, C. M., Lee, P. P., Gutierrez, P. R., Spritzer, K., Berry, S., & Hays, R. D. (2001). Development of the 25-item national eye institute visual function questionnaire. Archives of Ophthalmology,
119(7), 1050–1058.
PubMed
CAS
Google Scholar
Matchar, D. B., Suner, I. J., Samsa, G. P., McCrory, D. C., Cline, K., & Lee, P. P. (2005). Measuring quality of life for patients with age-related macular degeneration. Rockville, MD: Technology Assessment Program, US Agency for Healthcare Research and Quality.
Google Scholar
Mavranezouli, I., Brazier, J. E., Young, T. A. & Barkham, M. (2009). Using Rasch analysis to form plausible health states amenable to valuation: the development of CORE-6D from CORE-OM in order to elicit preferences for common mental health problems. Health Economics and Decision Science Discussion Paper Series No. 09/09: University of Sheffield.
Mangione, C. M. (2000). NEI VFQ-25 scoring algorithm. Rockville, MD: National Eye Institute.
Google Scholar
Mangione, C. M., Lee, P. P., Pitts, J., Gutierrez, P., Berry, S., Hays, R. D., et al. (1998). Psychometric properties of the national eye institute visual function questionnaire (NEI-VFQ). Archives of Ophthalmology,
116(11), 1496–1504.
PubMed
CAS
Google Scholar
Revicki, D., Rentz, A., Harnam, N., Thomas, V. & Lanzetta, P. (2010). Reliability and validity of the national eye institute visual function questionnaire-25 in patients with age-related macular degeneration. Investigative Ophthalmology and Visual Science, 51(2), 712–717.
Google Scholar
Submacular Surgery Trials Research Group. (2005). Health-related quality of life among patients with ocular histoplasmosis or idiopathic choroidal neovascularization at enrollment in a randomized trial of submacular surgery. SST report no. 5. Archives of Ophthalmology
123, 78–88.
Google Scholar
Clemons, T. E., Chew, E. Y., Bressler, S. B., & McBee, W. (2003). National eye institute visual function questionnaire in the age-related eye disease study (AREDS): AREDS report no. 10. Archives of Ophthalmology,
121(2), 211–217.
PubMed
Google Scholar
Lindblad, A. S., & Clemons, T. E. (2005). Responsiveness of the national eye institute visual function questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS report no. 14. Archives of Ophthalmology,
123(9), 1207–1214.
PubMed
Article
Google Scholar
Suner, I. J., Kokame, G. T., Yu, E., Ward, J., Dolan, C., & Bressler, N. M. (2009). Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: Validation studies from two phase 3 clinical trials. Investigative Ophthalmology and Visual Science,
50(8), 3629–3635.
PubMed
Article
Google Scholar
Bond, T. G., & Fox, C. M. (2007). Applying the Rasch model: Fundamental measurement in the human sciences. London: Psychology Press.
Google Scholar
Wright, B. D., & Masters, G. N. (1982). Rating scale analysis: Rasch measurement. Chicago: MESA Press.
Google Scholar
Rasch, G. (1980). Probabilistic models for some intelligence and attainment tests. Chicago: University of Chicago Press.
Google Scholar
Linacre, J. M. (1999). Investigating rating scale category utility. Journal of Outcome Measurement,
3(2), 103–122.
PubMed
CAS
Google Scholar
Kubinger, K. D. (2005). Psychological test calibration using the Rasch model-some critical suggestions on traditional approaches. International Journal of Testing,
5(4), 377–394.
Article
Google Scholar
RUMM 2020. (2004). Rasch unidimensional measurement models. Australia: RUMM Laboratory Pty Ltd.
Kind, P., & Macran, S. (2005). Eliciting social preference weights for functional assessment of cancer therapy-lung health states. Pharmacoeconomics,
23(11), 1143–1153.
PubMed
Article
Google Scholar
Allergan Inc. A study of the safety and efficacy of a new treatment for macular edema resulting from retinal vein occlusion. Baseline data on file at Allergan Inc.
Allergan Inc. A study of safety and efficacy of a new treatment for diabetic Macular Edema. Baseline data on file at Allergan Inc.
Schiffman, R. M., Walt, J. G., Jacobsen, G., Doyle, J. J., Lebovics, G., & Sumner, W. (2003). Utility assessment among patients with dry eye disease. Ophthalmology,
110(7), 1412–1419.
PubMed
Article
Google Scholar
Globe, D. R., Wu, J., Azen, S. P., & Varma, R. (2004). The impact of visual impairment on self-reported visual functioning in Latinos: The Los Angeles Latino eye study. Ophthalmology,
111(6), 1141–1149.
PubMed
Article
Google Scholar
Allergan Inc. Memantine in patients with chronic Glaucoma. Baseline data on file at Allergan Inc.
Muir, K. W., Santiago-Turla, C., Stinnett, S. S., Herndon, L. W., Allingham, R. R., Challa, P., et al. (2006). Health literacy and adherence to glaucoma therapy. American Journal of Ophthalmology,
142(2), 223–226.
PubMed
Article
Google Scholar